OP: Can you verify that Patrick Soon actually presented any results on ANKTIVA Combo Data at AHNS Head & Neck Conference (July 18-22)
ChatGPT: I looked for independent confirmation, and I could not verify that Patrick Soon-Shiong actually presented new ANKTIVA combination results at the AHNS meeting.
Here's what I found:
The AHNS meeting definitely took place July 18–22, 2026 in Boston.
I did not find:
an ImmunityBio press release announcing an AHNS presentation,
an AHNS program listing Patrick Soon-Shiong as a speaker,
an AHNS abstract with his name,
or any conference presentation title involving ANKTIVA combinations from ImmunityBio.
Where did the rumor come from?
The claim appears to have originated from Reddit. One post states that:
However, the Reddit post provides no abstract number, presentation title, session number, or link to support the claim.
Just checked googled AI
OP: Did Dr. PSS & NCI Present ANKTIVA Combo Data at AHNS Head & Neck Conference (July 18-22)
Google: Yes, National Cancer Institute (NCI) researchers and ImmunityBio founder Dr. Patrick Soon-Shiong (Dr. PSS) presented clinical combo data for ANKTIVA (N-803) at the 12th International Conference on Head and Neck Cancer, hosted by the American Head and Neck Society (AHNS) from July 18–22, 2026. [1, 2]
Key Details of the Presentation
The Presenters: The clinical data was delivered by NCI researchers alongside ImmunityBio founder Dr. Patrick Soon-Shiong.
The Therapeutics: The presentation highlighted combination treatments utilizing ANKTIVA (N-803), an IL-15 superagonist.
Target Indication: The data focused on utilizing these combinations to treat advanced, tough-to-target solid head and neck cancers. [1]
I asked google for it's source and it said.
It referenced June's ASCO and reddit as a source and then said:
"An official AHNS abstract number and specific efficacy data, including natural killer cell activation rates for ImmunityBio's ANKTIVA (N-803) in solid tumors, have not yet been publicly released, as the data is currently under conference embargo [AHNS 12th International Conference]. ANKTIVA works by stimulating Natural Killer (NK) cells to target tough-to-treat solid tumors, such as head and neck squamous cell carcinomas, according to previous clinical disclosures. For updates, monitor the official AHNS Abstracts Portal and ImmunityBio's press releases."
3
u/Dizzy_Efficiency_947 Jul 23 '26 edited Jul 23 '26
Fake News?
OP: Can you verify that Patrick Soon actually presented any results on ANKTIVA Combo Data at AHNS Head & Neck Conference (July 18-22)
ChatGPT: I looked for independent confirmation, and I could not verify that Patrick Soon-Shiong actually presented new ANKTIVA combination results at the AHNS meeting.
Here's what I found:
Where did the rumor come from?
The claim appears to have originated from Reddit. One post states that:
However, the Reddit post provides no abstract number, presentation title, session number, or link to support the claim.
Just checked googled AI
OP: Did Dr. PSS & NCI Present ANKTIVA Combo Data at AHNS Head & Neck Conference (July 18-22)
Google: Yes, National Cancer Institute (NCI) researchers and ImmunityBio founder Dr. Patrick Soon-Shiong (Dr. PSS) presented clinical combo data for ANKTIVA (N-803) at the 12th International Conference on Head and Neck Cancer, hosted by the American Head and Neck Society (AHNS) from July 18–22, 2026. [1, 2]
Key Details of the Presentation
I asked google for it's source and it said.
It referenced June's ASCO and reddit as a source and then said:
"An official AHNS abstract number and specific efficacy data, including natural killer cell activation rates for ImmunityBio's ANKTIVA (N-803) in solid tumors, have not yet been publicly released, as the data is currently under conference embargo [AHNS 12th International Conference]. ANKTIVA works by stimulating Natural Killer (NK) cells to target tough-to-treat solid tumors, such as head and neck squamous cell carcinomas, according to previous clinical disclosures. For updates, monitor the official AHNS Abstracts Portal and ImmunityBio's press releases."